CVAUSA (Cardiovascular Associates of America) — Account Dossier

Why This Company

Fit:

• PE-backed (Webster Equity Partners + Deerfield Management) cardiovascular MSO — 557+ physicians/APPs, 160+ locations, 8 states, ~$323M revenue, 1.3M patients/year. HIPAA-required. athenahealth EHR with proven IntelePeer integration via Redox partnership. (CVAUSA Partners; ZoomInfo; BusinessWire, June 2024; PR Newswire, Jan 2026)

Pain:

• Zero contact center automation across 160+ locations — each partner practice handles patient calls independently with no centralized phone system, IVR, or communication automation. No competing vendor detected at network or practice level. (Checked: CVAUSA website, LinkedIn, Indeed, Glassdoor, ZoomInfo, vendor sites — February 2026)
• Documented phone strain at partner practices — Heart & Vascular Care (Georgia/CVAUSA partner) experienced "understaffing and inefficiencies in internal communication" and their lack of online booking "resulted in high call volumes, affecting patient experience and staff productivity." (ZTown Media Case Study)
• VBC contracts requiring proactive patient outreach — active value-based care agreements with Humana (Medicare Advantage), InnovaCare, and Prospect Health Services require chronic disease management communication, care coordination, and appointment adherence at scale across the network. (CVAUSA News)

Timing:

• Actively selecting "preferred" technology platforms — 4 major partnerships in 18 months: athenahealth (June 2024), Clinii virtual care (Jan 2025), HybridChart rounding (June 2025), Ascertain AI prior auth (Jan 2026). Patient communication automation is the obvious next frontier — the window to become the "preferred communications automation platform" is open now. (CVAUSA News; PR Newswire, Jan 2026)
• PE exit trajectory creating urgency — Webster Equity Partners exited Retina Consultants of America at $4.6B (from $350M investment, Nov 2024). Their playbook: scale → standardize → technology-enable → exit. CVAUSA is in the "technology-enable" phase. (Goodwin, Nov 2024)

---

Decision Makers

Ben Diestel, MBA — SVP Innovation / GM Central-South Florida / VP Corporate Development

Recommended Entry Point / Innovation Gatekeeper

• LinkedIn: linkedin.com/in/ben-diestel-9a7a9221
• Email: bdiestel@cvausa.com (inferred — RocketReach; ZoomInfo)
• Cares about:
  • Technology partnerships for operational scale — quoted in Ascertain press release (Jan 2026): "Ascertain's agentic AI platform gives us the ability to address that challenge at scale, freeing our physicians and staff to focus on what they do best: saving lives." (PR Newswire, Jan 2026)
  • Industry innovation recognition — Named to Cardiovascular Business "40 Under 40" (2025). Columbia Business School MBA. (Cardiovascular Business)
• Why they matter: He is the spokesperson and gatekeeper for CVAUSA's technology partnerships — the person who sources, evaluates, and champions "preferred platform" selections. His dual role (innovation + Florida operations) gives him both strategic vision and daily operational pain visibility.

---

Sean Cofoid — Chief Data Officer

Potential Champion / AI Advocate

• LinkedIn: linkedin.com/in/seancofoid
• Email: scofoid@cvausa.com (inferred — RocketReach)
• Cares about:
  • Data transformation and AI — his quote (July 2025): "The opportunity to bring together data from across a diverse national network and use it to transform care delivery is incredibly exciting." (CVAUSA News)
  • Generative AI deployment — deployed four generative AI applications at a large health system in his prior role. Career spans HCA, Envision Healthcare, and Wayspring (healthcare data startup). (CVAUSA News)
• Why they matter: Newly appointed CDO (July 2025) with hands-on generative AI deployment experience, reports directly to CEO. Building his data function from scratch — IntelePeer's SmartAnalytics generating call/intent data across 160+ locations feeds his mandate directly.

---

Jack Sunderman — Chief Information Officer

Technical Evaluator

• LinkedIn: linkedin.com/in/jacksunderman
• Email: jsunderman@cvausa.com (inferred — RocketReach)
• Cares about:
  • Enterprise-wide technology solutions — "provides strategic direction to executive management on technology and implementing robust enterprise-wide solutions." (EIN Presswire)
  • Compliance and security — SSAE 16 SOC2, PCI/DSS, HIPAA audit experience. (EIN Presswire)
• Why they matter: 20+ years healthcare IT; prior CIO at Center for Primary Care (multi-location practice) — understands the exact infrastructure fragmentation problem. Will evaluate technical integration (athenahealth/Redox, telephony overlay) and security (IntelePeer's HIPAA, SOC 2 Type 2, ISO 42001 certifications).

---

Tim Attebery, DSc, MBA, FACHE — CEO

Ultimate Decision Maker

• LinkedIn: linkedin.com/in/timothy-attebery-dsc-mba-fache-b06442b6
• Email: attebery@cvausa.com (verified — CVAUSA partnership contact page)
• Cares about:
  • Technology-enabled operational excellence — quoted on HybridChart partnership (2025): "Their solution provides our partner groups with a powerful tool to enhance workflow efficiency and capture vital patient data." (Cardiovascular Business, June 2025)
  • Physician autonomy within shared infrastructure — CVAUSA model preserves clinical autonomy while providing shared resources and preferred technology platforms. (CVAUSA Our Model; CVAUSA News)
• Why they matter: Co-founded CVAUSA with Webster Equity Partners. 36 years healthcare leadership (former CEO of American College of Cardiology and MedAxiom). Signs off on all enterprise-wide "preferred platform" deployments — but would not be the first conversation. Also Board Chairman of CorVista Health (AI cardiac diagnostics). (CorVista)

---

Jesse VanGeison — VP Central Operations & Healthcare Practice Integration

Influencer / Integration Playbook Owner

• LinkedIn: linkedin.com/in/jesse-vangeison-83787a5
• Email: jvangeison@cvausa.com (inferred — ZoomInfo)
• Cares about:
  • Standardizing integration of newly acquired practices — led Integration Management Office at United Urology Group (~4.5 years) before CVAUSA. (ZoomInfo)
  • Multi-channel communication and campaign orchestration — 9 years at T. Rowe Price leading marketing and communication campaign strategy. (ZoomInfo)
• Why they matter: Owns the playbook for integrating every practice CVAUSA acquires (~5+/year). A standardized IntelePeer deployment as part of the integration process — "same trusted local numbers" preserved, automated capabilities added — would become his initiative. His communication campaign background makes him a natural advocate for patient outreach automation.

---

Fang Xia, CPA, MAcc — CFO

Budget Authority

• LinkedIn: linkedin.com/in/fang-xia-cpa-macc-79ba4677
• Email: fxia@cvausa.com (inferred — RocketReach)
• Cares about:
  • ROI validation for PE sponsors — prior CFO at US Anesthesia Partners (PE-backed physician platform), understands the EBITDA/exit multiple playbook. (Tampa FP, Jan 2022)
  • Cost management during rapid growth — ~60% location growth in 12 months with 5+ acquisitions. (CVAUSA website)
• Why they matter: Validates the business case for Webster Equity Partners. Speaks the language of staff cost reduction per location, revenue recovery from automated billing, and operational consistency supporting premium exit valuation.

---

Samantha Meadors, RN, CHC — COO

Influencer (Operations)

• LinkedIn: linkedin.com/in/samanthameadors
• Email: smeadors@cvausa.com (inferred — RocketReach)
• Cares about:
  • Operational efficiency across acquired practices — 20+ years healthcare executive, expertise includes "due diligence and mergers and acquisition integration." (CVAUSA Leadership)
  • Regulatory compliance — CHC certified, RN background, HIPAA and internal audit experience. (CVAUSA Leadership)
• Why they matter: Owns operational efficiency mandate across 160+ fragmented locations. Her buy-in is essential for adoption — she feels the daily pain of inconsistent patient communications across the network.

---

Entry Strategy

Recommended Entry Point: Ben Diestel

He is the technology partnership gatekeeper — the spokesperson for the Ascertain AI deal (January 2026), the most recent "preferred platform" selection. His quote demonstrates he thinks in terms of "operational automation at scale." (PR Newswire, Jan 2026) The Ascertain adjacency provides natural context: CVAUSA has automated prior authorizations — patient communication automation is the logical next step. His dual role (innovation + Florida operations) means he sees both the strategic opportunity and daily operational pain at the practice level. Columbia MBA, Cardiovascular Business "40 Under 40" (2025), founding member of Novocardia (pre-merger CVAUSA entity). (Cardiovascular Business)

Potential Champion: Sean Cofoid

Newly appointed CDO (July 2025) who deployed four generative AI applications at a large health system in his prior role. (CVAUSA News) He would immediately understand SmartAgent's architecture and value proposition. Reports directly to CEO Tim Attebery — maximum influence. As CDO building his data function from scratch, IntelePeer's SmartAnalytics generating call/intent/sentiment data across 160+ locations feeds his mandate directly.

Note: No personal warm introduction paths exist between CVAUSA and IntelePeer leadership. The strongest available path is institutional: Deerfield Management is a CVAUSA co-investor AND investor in Ascertain AI (whose CEO became Deerfield's CIO). Deerfield manages $15B+ in healthcare assets with a $600M+ Healthcare Innovations Fund specifically targeting AI/ML in healthcare. (PR Newswire, Deerfield Fund III; PR Newswire, Ascertain Series A) If IntelePeer has or can build a Deerfield relationship, that is the highest-probability introduction path.

---

Key Context

• Clean whitespace — no vendor to displace: No evidence of any contact center, IVR, CCaaS, or communication automation vendor at CVAUSA at network or practice level. Searched: CVAUSA website, LinkedIn, Indeed, Glassdoor, ZoomInfo, NICE/Genesys/Five9/Avaya/Cisco vendor sites — February 2026.
• Webster portfolio multiplier: CVAUSA is one of 20+ companies in Webster's healthcare portfolio. Winning CVAUSA opens doors to additional multi-location healthcare platforms — most immediately One GI (gastroenterology MSO, 195 physicians, 65 locations, 6 states), directly analogous to IntelePeer's existing Allied Digestive Health deployment. (Webster Equity Partners Portfolio; Goodwin, April 2020)
• "Preferred platform" adoption model: CVAUSA negotiates technology at the network level and offers preferred/discounted access to partner practices — despite each practice maintaining operational autonomy. athenahealth, Clinii, HybridChart, and Ascertain were all deployed this way. IntelePeer would follow the same model: network-level deal, phased practice adoption. (CVAUSA Our Model)

---

Quick Reference

---